This triple-blind randomized controlled trial enrolled 30 adults with difficult-to-control asthma to evaluate whether adding LED-based photobiomodulation therapy (LEDT) to resistance training (RT) enhances outcomes. Participants were assigned to RT+LEDT or RT alone with placebo photobiomodulation for 12 weeks.
The primary outcome was peripheral muscle strength measured by one-repetition maximum (1RM). The RT+LEDT group showed greater gains in 1RM compared to RT alone. Secondary outcomes included oxygen consumption at anaerobic threshold and shuttle walk test distance, both of which significantly improved in the RT+LEDT group. However, pulmonary function and asthma control did not differ between groups.
No safety data, adverse events, or discontinuations were reported. The study did not report effect sizes, confidence intervals, or p-values, limiting the ability to assess the magnitude or precision of the findings. The small sample size (n=30) further reduces certainty.
Clinically, the results suggest that adding photobiomodulation to resistance training may offer additional benefits for muscle strength and functional capacity in patients with difficult-to-control asthma. However, the lack of effect sizes and safety data, combined with the small sample, means these findings should be considered preliminary until confirmed in larger, well-powered trials.
View Original Abstract ↓
Difficult-to-Control Asthma (DTCA) is characterized by persistent symptoms, frequent exacerbations, and reduced functional capacity despite optimized pharmacological therapy. Patients with DTCA commonly exhibit peripheral muscle dysfunction, making strategies that may potentiate the effects of resistance training clinically relevant. Photobiomodulation therapy (PBMT) has been investigated as a modality capable of improving muscle performance and exercise tolerance. The aim of this study was to determine whether combining resistance training with LED-based PBMT (RT+LEDT) results in greater improvements in peripheral muscle strength and functional exercise capacity compared with resistance training alone in adults with DTCA. This randomized, triple-blind controlled trial included 30 adults with DTCA who met predefined inclusion and exclusion criteria. Participants were allocated equally to an experimental group (RT+LEDT; n = 15) or a control group (RT; n = 15). Both groups completed supervised resistance training twice weekly for 12 weeks. The experimental group received active PBMT before each session, while the control group received placebo PBMT. The primary outcome was peripheral muscle strength assessed by one-repetition maximum (1RM). Secondary outcomes included cardiopulmonary exercise test variables, shuttle walk test performance, spirometry, physical activity level, and asthma control. Post-intervention group comparisons were performed using independent t-tests. Compared with RT alone, RT+LEDT produced greater post-treatment gains in 1RM strength across major muscle groups, along with significant improvements in oxygen consumption at the anaerobic threshold and shuttle walk test distance. No between-group differences were observed in pulmonary function or asthma control. PBMT combined with resistance training yielded clinically meaningful improvements in muscle strength and functional capacity, suggesting its potential as an adjunctive strategy in rehabilitation programs for DTCA.